Literature DB >> 25623789

Dementia in 2014. Towards early diagnosis in Alzheimer disease.

Agneta Nordberg1.   

Abstract

Improved neuroimaging and molecular markers of Alzheimer disease (AD) have aided diagnosis of AD in the very early stages, and have facilitated differential diagnosis between AD and other neurodegenerative disorders with dementia. The finding that some older individuals can show amyloid-β pathology while remaining cognitively intact raises important questions regarding prevention strategies.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25623789     DOI： 10.1038/nrneurol.2014.257

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


  10 in total

1.  Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.

Authors:  Nobuyuki Okamura; Shozo Furumoto; Michelle T Fodero-Tavoletti; Rachel S Mulligan; Ryuichi Harada; Paul Yates; Svetlana Pejoska; Yukitsuka Kudo; Colin L Masters; Kazuhiko Yanai; Christopher C Rowe; Victor L Villemagne
Journal:  Brain       Date:  2014-03-27       Impact factor: 13.501

2.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Harald Hampel; José Luis Molinuevo; Kaj Blennow; Steven T DeKosky; Serge Gauthier; Dennis Selkoe; Randall Bateman; Stefano Cappa; Sebastian Crutch; Sebastiaan Engelborghs; Giovanni B Frisoni; Nick C Fox; Douglas Galasko; Marie-Odile Habert; Gregory A Jicha; Agneta Nordberg; Florence Pasquier; Gil Rabinovici; Philippe Robert; Christopher Rowe; Stephen Salloway; Marie Sarazin; Stéphane Epelbaum; Leonardo C de Souza; Bruno Vellas; Pieter J Visser; Lon Schneider; Yaakov Stern; Philip Scheltens; Jeffrey L Cummings
Journal:  Lancet Neurol       Date:  2014-06       Impact factor: 44.182

3.  Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls.

Authors:  Masahiro Maruyama; Hitoshi Shimada; Tetsuya Suhara; Hitoshi Shinotoh; Bin Ji; Jun Maeda; Ming-Rong Zhang; John Q Trojanowski; Virginia M-Y Lee; Maiko Ono; Kazuto Masamoto; Harumasa Takano; Naruhiko Sahara; Nobuhisa Iwata; Nobuyuki Okamura; Shozo Furumoto; Yukitsuka Kudo; Qing Chang; Takaomi C Saido; Akihiko Takashima; Jada Lewis; Ming-Kuei Jang; Ichio Aoki; Hiroshi Ito; Makoto Higuchi
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173

4.  Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.

Authors:  Anne M Fagan; Chengjie Xiong; Mateusz S Jasielec; Randall J Bateman; Alison M Goate; Tammie L S Benzinger; Bernardino Ghetti; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Stephen Salloway; Peter R Schofield; Reisa A Sperling; Daniel Marcus; Nigel J Cairns; Virginia D Buckles; Jack H Ladenson; John C Morris; David M Holtzman
Journal:  Sci Transl Med       Date:  2014-03-05       Impact factor: 17.956

5.  Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.

Authors:  Clifford R Jack; Heather J Wiste; Stephen D Weigand; Walter A Rocca; David S Knopman; Michelle M Mielke; Val J Lowe; Matthew L Senjem; Jeffrey L Gunter; Gregory M Preboske; Vernon S Pankratz; Prashanthi Vemuri; Ronald C Petersen
Journal:  Lancet Neurol       Date:  2014-09-04       Impact factor: 44.182

6.  Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals.

Authors:  Elizabeth C Mormino; Rebecca A Betensky; Trey Hedden; Aaron P Schultz; Rebecca E Amariglio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling
Journal:  JAMA Neurol       Date:  2014-11       Impact factor: 18.302

7.  Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.

Authors:  David T Chien; A Katrin Szardenings; Shadfar Bahri; Joseph C Walsh; Fanrong Mu; Chunfang Xia; William R Shankle; Alan J Lerner; Min-Ying Su; Arkadij Elizarov; Hartmuth C Kolb
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

8.  Primary age-related tauopathy (PART): a common pathology associated with human aging.

Authors:  John F Crary; John Q Trojanowski; Julie A Schneider; Jose F Abisambra; Erin L Abner; Irina Alafuzoff; Steven E Arnold; Johannes Attems; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Dennis W Dickson; Marla Gearing; Lea T Grinberg; Patrick R Hof; Bradley T Hyman; Kurt Jellinger; Gregory A Jicha; Gabor G Kovacs; David S Knopman; Julia Kofler; Walter A Kukull; Ian R Mackenzie; Eliezer Masliah; Ann McKee; Thomas J Montine; Melissa E Murray; Janna H Neltner; Ismael Santa-Maria; William W Seeley; Alberto Serrano-Pozo; Michael L Shelanski; Thor Stein; Masaki Takao; Dietmar R Thal; Jonathan B Toledo; Juan C Troncoso; Jean Paul Vonsattel; Charles L White; Thomas Wisniewski; Randall L Woltjer; Masahito Yamada; Peter T Nelson
Journal:  Acta Neuropathol       Date:  2014-10-28       Impact factor: 17.088

9.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.

Authors:  Sam Norton; Fiona E Matthews; Deborah E Barnes; Kristine Yaffe; Carol Brayne
Journal:  Lancet Neurol       Date:  2014-08       Impact factor: 44.182

10.  Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.

Authors:  Tammie L S Benzinger; Tyler Blazey; Clifford R Jack; Robert A Koeppe; Yi Su; Chengjie Xiong; Marcus E Raichle; Abraham Z Snyder; Beau M Ances; Randall J Bateman; Nigel J Cairns; Anne M Fagan; Alison Goate; Daniel S Marcus; Paul S Aisen; Jon J Christensen; Lindsay Ercole; Russ C Hornbeck; Angela M Farrar; Patricia Aldea; Mateusz S Jasielec; Christopher J Owen; Xianyun Xie; Richard Mayeux; Adam Brickman; Eric McDade; William Klunk; Chester A Mathis; John Ringman; Paul M Thompson; Bernardino Ghetti; Andrew J Saykin; Reisa A Sperling; Keith A Johnson; Stephen Salloway; Stephen Correia; Peter R Schofield; Colin L Masters; Christopher Rowe; Victor L Villemagne; Ralph Martins; Sebastien Ourselin; Martin N Rossor; Nick C Fox; David M Cash; Michael W Weiner; David M Holtzman; Virginia D Buckles; Krista Moulder; John C Morris
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-05       Impact factor: 11.205
  10 in total
  18 in total

Review 1.  Olfactory Identification Deficits, Cognitive Decline, and Dementia in Older Adults.

Authors:  D P Devanand
Journal:  Am J Geriatr Psychiatry       Date:  2016-08-17       Impact factor: 4.105

2.  Neuroimaging biomarkers and impaired olfaction in cognitively normal individuals.

Authors:  Maria Vassilaki; Teresa J Christianson; Michelle M Mielke; Yonas E Geda; Walter K Kremers; Mary M Machulda; David S Knopman; Ronald C Petersen; Val J Lowe; Clifford R Jack; Rosebud O Roberts
Journal:  Ann Neurol       Date:  2017-06-09       Impact factor: 10.422

3.  Genetic risk for Alzheimer's disease and functional brain connectivity in children and adolescents.

Authors:  Luiza Kvitko Axelrud; João Ricardo Sato; Marcos Leite Santoro; Fernanda Talarico; Daniel Samuel Pine; Luis Augusto Rohde; Andre Zugman; Edson Amaro Junior; Rodrigo Affonseca Bressan; Rodrigo Grassi-Oliveira; Pedro Mario Pan; Maurício Scopel Hoffmann; Andre Rafael Simioni; Salvador Martin Guinjoan; Hakon Hakonarson; Elisa Brietzke; Ary Gadelha; Renata Pellegrino da Silva; Marcelo Queiroz Hoexter; Euripedes Constantino Miguel; Sintia Iole Belangero; Giovanni Abrahão Salum
Journal:  Neurobiol Aging       Date:  2019-07-06       Impact factor: 4.673

Review 4.  miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease.

Authors:  Gohar Mushtaq; Nigel H Greig; Firoz Anwar; Mazin A Zamzami; Hani Choudhry; Munvar M Shaik; Ian A Tamargo; Mohammad A Kamal
Journal:  Med Chem       Date:  2016       Impact factor: 2.745

Review 5.  The Role of Natural Antioxidants in the Prevention of Dementia-Where Do We Stand and Future Perspectives.

Authors:  Anamaria Jurcau
Journal:  Nutrients       Date:  2021-01-20       Impact factor: 5.717

6.  A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using 18F-FDG PET of the Brain.

Authors:  Yiming Ding; Jae Ho Sohn; Michael G Kawczynski; Hari Trivedi; Roy Harnish; Nathaniel W Jenkins; Dmytro Lituiev; Timothy P Copeland; Mariam S Aboian; Carina Mari Aparici; Spencer C Behr; Robert R Flavell; Shih-Ying Huang; Kelly A Zalocusky; Lorenzo Nardo; Youngho Seo; Randall A Hawkins; Miguel Hernandez Pampaloni; Dexter Hadley; Benjamin L Franc
Journal:  Radiology       Date:  2018-11-06       Impact factor: 29.146

7.  Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease.

Authors:  Liang Feng; Yu-Ting Liao; Jin-Cai He; Cheng-Long Xie; Si-Yan Chen; Hui-Hui Fan; Zhi-Peng Su; Zhen Wang
Journal:  BMC Neurol       Date:  2018-01-09       Impact factor: 2.474

8.  Hyperplanar Morphological Clustering of a Hippocampus by Using Volumetric Computerized Tomography in Early Alzheimer's Disease.

Authors:  Sarawut Suksuphew; Paramate Horkaew
Journal:  Brain Sci       Date:  2017-11-21

9.  A Hierarchical Feature and Sample Selection Framework and Its Application for Alzheimer's Disease Diagnosis.

Authors:  Le An; Ehsan Adeli; Mingxia Liu; Jun Zhang; Seong-Whan Lee; Dinggang Shen
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379

Review 10.  Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease.

Authors:  Anna Chiarini; Ubaldo Armato; Daisong Liu; Ilaria Dal Prà
Journal:  Front Physiol       Date:  2016-04-26       Impact factor: 4.566
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.